Peter Garcia
2015 - PDL BioPharma
In 2015, Peter Garcia earned a total compensation of $1.5M as Vice President and Chief Financial Officer at PDL BioPharma, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $694,933 |
|---|---|
| Salary | $417,768 |
| Stock Awards | $325,384 |
| Other | $58,000 |
| Total | $1,496,085 |
Garcia received $694.9K in non-equity incentive plan, accounting for 46% of the total pay in 2015.
Garcia also received $417.8K in salary, $325.4K in stock awards and $58K in other compensation.
Rankings
In 2015, Peter Garcia's compensation ranked 6,011th out of 13,638 executives tracked by ExecPay. In other words, Garcia earned more than 55.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,011 out of 13,638 | 56th |
Division Manufacturing | 2,249 out of 5,187 | 57th |
Major group Chemicals And Allied Products | 813 out of 1,857 | 56th |
Industry group Drugs | 650 out of 1,531 | 58th |
Industry Biological Products, Except Diagnostic Substances | 113 out of 260 | 57th |
Source: SEC filing on April 28, 2017.
Garcia's colleagues
We found five more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2015.
2015
John McLaughlin
PDL BioPharma
Chief Executive Officer
2015
Christopher Stone
PDL BioPharma
General Counsel
2015
Danny Hart
PDL BioPharma
Vice President, Business Development
2015
David Montez
PDL BioPharma
Chief Accounting Officer
2015
Steffen Pietzke
PDL BioPharma
Chief Accounting Officer
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019